KIMBERLY DRUMMOND: Open Payments
NPI 1407508468 · BOWLING GREEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 126 payments from 19 companies in 2025. Trend: 2023 $2,248 · 2024 $2,188 · 2025 $2,185
Food & beverage: $2,185
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $315 |
| Teva Pharmaceuticals USA, Inc. | 10 | $238 |
| E.R. Squibb & Sons, L.L.C. | 6 | $191 |
| Alkermes, Inc. | 14 | $184 |
| Otsuka America Pharmaceutical, Inc. | 17 | $167 |
| ABBVIE INC. | 11 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $166 |
| Janssen Pharmaceuticals, Inc | 7 | $138 |
| Supernus Pharmaceuticals, Inc. | 7 | $129 |
| Lundbeck LLC | 5 | $96 |
Products named: INGREZZA, REXULTI, AUSTEDO XR, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, Qelbree.
Industry payments across OH — which companies pay providers there.
